AUSTRALIAN CLINICAL LABS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.46 AUD | -1.20% |
|
+3.80% | -14.88% |
| Mar. 05 | Australia shares inch lower as miners weigh; GDP data in focus | RE |
| Feb. 28 | Australian Clinical Labs Falls 11% After Trimming Interim Dividend on Lower H1 FY24 EPS | MT |
Presenter SpeechEleanor Padman (Executives)Good morning, everyone. On behalf of ACL, I'd like ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.
Calendar
2024-08-21
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.46
AUD
Average target price
3.096
AUD
Spread / Average Target
+25.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.88% | 322M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- ACL Stock
- News Australian Clinical Labs Limited
- Transcript : Australian Clinical Labs Limited, H1 2024 Earnings Call, Feb 28, 2024
